Forest Laboratories, Inc. Announces Health Canada Approval of BYSTOLIC for the Treatment of Hypertension

[at noodls] – NEW YORK–(BUSINESS WIRE)–Forest Laboratories, Inc. (NYSE:FRX) announced today that its Canadian subsidiary, Forest Laboratories Canada Inc. has received a Notice of Compliance from Health Canada for … more

View todays social media effects on FRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Forest is hiring next, click here to view